HER2 Negative Breast Adenocarcinoma
1 clinical trials · Condition
◉ Watch HER2 Negative Breast Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Abemaciclib and Niraparib Before Surgery for the Treatment of Hormone Receptor Positive HER2 Negative Breast Cancer (NCT04481113) | OHSU Knight Cancer Institute | 2021-06-07 |
Track HER2 Negative Breast Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.